More than 600 pathogenic variants in the BMPR2 gene have been identified so far, accounting for the disease development in about 85% of HPAH and 5–35% of IPAH patients [3]. This evidence concerns the gene BMPR2 and idiopathic pulmonary arterial hypertension.